# Noble Molecules

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/noble-molecules

- Industry: Pharmaceuticals
- Headquarters: Boulder, US
- Website: www.noblemolecules.com
- Total disclosed funding: $0.5M
- Latest round: Series A (Aug 3, 2006)
- Investors on record: 1

## About

Noble Molecules, Inc. focuses on developing and commercializing advanced materials, particularly specialty chemicals and innovative polymer solutions, tailored for high-performance industrial applications in sectors such as aerospace, automotive, and electronics.Noble Molecules, Inc. is engaged in the development of specialized materials for various industries. The company is headquartered in Boulder, US. Founded by Alain Cappeluti and Kenneth Carter, it has secured funding, including USD 0.5 mn in Series A funding led by Sequel Venture Partners on August 3, 2006, which accounts for the total amount raised. The current CEO is Srujana Cherukuri.Noble Molecules specializes in the development and commercialization of advanced materials designed for a variety of industrial applications. Their core product offerings focus on specialty chemicals and innovative polymer solutions, which are engineered to meet high-performance standards in sectors such as aerospace, automotive, and electronics. The company aims to solve critical challenges including durability, weight reduction, and efficiency in material use, facilitating the adoption of these materials across numerous industries. Noble Molecules serves a diverse clientele, including manufacturers, product developers, and end-users in North America, Europe, and parts of Asia. The introduction of their flagship products has been strategically timed to align with growing market demands for sustainable and high-performance materials.Noble Molecules generates revenue through a structured model that primarily involves B2B transactions with manufacturers and industrial partners. The company engages in contractual agreements, where clients place orders for customized chemical solutions tailored to their specific operational needs. Transactions are structured around volume-based pricing, enabling clients to benefit from economies of scale while ensuring consistent supply. Pricing plans for their products are designed to reflect the quality and performance advantages they provide, particularly for their trademarked materials, which are positioned as premium offerings in the market. By fostering long-term partnerships and providing technical support, Noble Molecules enhances its value proposition to clients, ensuring ongoing revenue streams.Noble Molecules plans to leverage the recent funding of USD 0.5 mn raised in Series A to explore new product designs and launches, focusing on innovative materials that meet evolving industrial standards. The company is targeting expansion into European and Asian markets by 2025, aiming to tap into increasing demand for sustainable industrial materials. This strategic move is aligned with their mission to address market needs while utilizing their advanced chemical solutions.

## Funding rounds

- Series A, Aug 3, 2006, $0.5M — Sequel Venture Partners

## Investors

- Sequel Venture Partners (https://capitalatlas.ai/funds/sequel-venture-partners) — Series A